CDEK
← All organizations

Sirion Therapeutics

For profitContributed to NMEWebsite ↗
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2007

First marketed drug

Jun 23, 2008

First NDA

Jun 23, 2008

Last known activity

Jan 1, 2008

Acquired by Perkin Elmer Inc. on Jun 22, 2021

Timeline

2000s

  1. Jan 1, 2007

    Sirion Therapeutics— Founded

  2. Jun 23, 2008

    difluprednate— NDA Organization

2010s

  1. Jun 18, 2010

    Rx Development Resources, LLC— Acquired

2020s

  1. Jun 22, 2021

    Perkin Elmer Inc.— Acquired By

Drugs by trial phase (5 distinct, 16 trials)

Phase 3 (3 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (21)

Details

Founded
Martinsried, DE Jan 1, 2007
First NDA
Jun 23, 2008
Last known activity
Jan 1, 2008

Designations held

  • Priority review